Back to Agenda
Tolerability in Immuno-Oncology: Patient Experience as a Core Element of Clinical Trials
Session Chair(s)
Devin Peipert
Assistant Professor, Feinberg School of Medicine
Northwestern University, United States
Update on a DIA study advancing patient experience data to assess tolerability in immuno-oncology trials, highlighting conceptual model progress and stakeholder insights for regulatory decisions.
Learning Objective : Update on DIA study integrating patient experience into immuno-oncology tolerability assessments; review findings from literature and KOL interviews; explore strategies for operationalizing a multidimensional tolerability framework; understand multistakeholder perspectives to support trial design, data collection, and benefit–risk evaluation.
Speaker(s)
Panelist
Maria Paula Bautista Acelas, MSC
DIA, United States
Senior Scientific Project Manager
Angela Rylands
Kyowa Kirin International , United Kingdom
Global Head of Patient Centred Outcomes
Panelist
Lia Ridout
-, United States
Patient Advocate
Regulatory Perspective
Representative Invited
FDA, United States
Have an account?